MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09537104.2025.2487767

Медицинская библиотека · Platelets · 2025

Immune-induced thrombocytopenia by pembrolizumab: case report and review of literature.

El-Ghazzi Nathan, Monier Anna, Italiano Antoine, Besson Aude, Angeli Eurydice

СтатьяКлинический случайОбзорПеревод пока не подготовлен

Аннотация

Immune-checkpoint blockades (ICBs) are now used in early-stage diseases like triple-negative breast cancer (TNBC). While effective, they can cause severe toxicities. We report the first case of life-threatening immune thrombocytopenia (ITP) induced by pembrolizumab during neoadjuvant chemo-immunotherapy for early TNBC. A 42-year-old woman with early-stage TNBC developed grade 4 thrombocytopenia, diagnosed as ITP, after 107 days of pembrolizumab treatment. She required intensive care unit (ICU) admission and high-dose steroids, and intravenous immunoglobulin therapy, leading to a rapid recovery. ITP is a rare but potentially fatal complication of immunotherapy, with an incidence of less than 1% and a mortality rate of up to 20% in affected patients. Immediate recognition and steroid therapy are critical, as platelet transfusion is usually ineffective. Diagnosis is often delayed due to its similarity to chemotherapy-induced marrow toxicity. Immunotherapy-induced ITP generally contraindicates further use of the treatment. ITP, although uncommon, is a serious complication of immunotherapy requiring immediate intervention. The growing use of immunotherapy necessitates increased awareness of its potential toxicities among healthcare providers.

Для цитирования: El-Ghazzi Nathan, Monier Anna, Italiano Antoine, Besson Aude, Angeli Eurydice. Immune-induced thrombocytopenia by pembrolizumab: case report and review of literature.. Platelets. 2025. DOI: 10.1080/09537104.2025.2487767.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.